Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Endeavor Biomedicines, Inc.
Eli Lilly and Company
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Shanghai 6th People's Hospital
Institut Bergonié
University of Minnesota
Milton S. Hershey Medical Center
University of Milano Bicocca
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Institut Bergonié
Children's Oncology Group
Istituto Ortopedico Rizzoli
National Cancer Institute (NCI)
Children's National Research Institute
Children's National Research Institute
Taproot Health
National Cancer Institute (NCI)
Emory University
Children's Oncology Group
Grupo Espanol de Investigacion en Sarcomas
Peking University People's Hospital
Eisai Inc.
Children's Oncology Group
Hutchmed
Italian Sarcoma Group
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chinese University of Hong Kong
Children's Cancer Hospital Egypt 57357
Washington University School of Medicine
Children's Oncology Group
Peking University People's Hospital
Stanford University
University Health Network, Toronto
First Affiliated Hospital, Sun Yat-Sen University
Children's Oncology Group
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
Emory University